SCM
WST icon

Sandler Capital Management’s West Pharmaceutical WST Stock Holding History

Sandler Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,033
Closed -$5.58M – 183
2024
Q4 		$5.58M Buy
+17,033
New +$5.36M 0.58% 70
2024
Q2 		– Sell
-14,694
Closed -$5.81M – 175
2024
Q1 		$5.81M Sell
14,694
-30,270
-67% -$11.2M 0.42% 89
2023
Q4 		$15.8M Buy
44,964
+27,210
+153% +$9.63M 1.31% 26
2023
Q3 		$6.66M Buy
17,754
+4,754
+37% +$1.84M 0.69% 60
2023
Q2 		$4.97M Sell
13,000
-1,964
-13% -$702K 0.41% 73
2023
Q1 		$5.18M Buy
+14,964
New +$4.37M 0.47% 67
2021
Q1 		– Sell
-11,477
Closed -$3.25M – 128
2020
Q4 		$3.25M Sell
11,477
-19,100
-62% -$5.36M 0.38% 65
2020
Q3 		$8.41M Sell
30,577
-55,693
-65% -$14.7M 0.84% 41
2020
Q2 		$19.6M Buy
+86,270
New +$17M 1.87% 18
2017
Q3 		– Sell
-70,024
Closed -$6.62M – 163
2017
Q2 		$6.62M Sell
70,024
-65,720
-48% -$6.04M 0.72% 51
2017
Q1 		$11.1M Buy
135,744
+25,844
+24% +$2.16M 0.76% 35
2016
Q4 		$9.32M Buy
109,900
+44,900
+69% +$3.53M 0.84% 43
2016
Q3 		$4.84M Buy
+65,000
New +$5.16M 0.59% 63
2015
Q3 		– Sell
-90,997
Closed -$5.29M – 200
2015
Q2 		$5.29M Sell
90,997
-45,083
-33% -$2.52M 0.47% 89
2015
Q1 		$8.19M Sell
136,080
-25,120
-16% -$1.34M 0.51% 75
2014
Q4 		$8.58M Buy
161,200
+81,200
+102% +$4.06M 0.45% 76
2014
Q3 		$3.58M Buy
+80,000
New +$3.4M 0.17% 150

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Sandler Capital Management's WST Position: Q1 2025 in Review

Sandler Capital Management sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 17,033 shares — an estimated $5.58M sold.

Sandler Capital Management first reported a position in WST in Q3 2014 and held it in 17 quarters. The position peaked at $19.6M in Q2 2020. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Sandler Capital Management reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Sandler Capital Management sold 17,033 West Pharmaceutical shares in Q1 2025, an estimated $5.58M.
  • Sandler Capital Management first reported a position in West Pharmaceutical in Q3 2014 and held it in 17 quarters.
  • Sandler Capital Management's West Pharmaceutical position peaked at $19.6M in Q2 2020.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Sandler Capital Management's 13F filing for Q1 2025, filed 15 May 2025.